nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2D6—Parkinson's disease	0.541	0.583	CbGaD
Desloratadine—ABCB1—Parkinson's disease	0.387	0.417	CbGaD
Desloratadine—Loratadine—CYP2D6—Parkinson's disease	0.0014	0.154	CrCbGaD
Desloratadine—Amoxapine—HTR7—Parkinson's disease	0.00109	0.12	CrCbGaD
Desloratadine—Amoxapine—DRD3—Parkinson's disease	0.00103	0.113	CrCbGaD
Desloratadine—Amoxapine—DRD1—Parkinson's disease	0.00101	0.111	CrCbGaD
Desloratadine—Loratadine—ABCB1—Parkinson's disease	0.001	0.11	CrCbGaD
Desloratadine—Amoxapine—SLC6A3—Parkinson's disease	0.000957	0.105	CrCbGaD
Desloratadine—Amoxapine—HTR1A—Parkinson's disease	0.000839	0.0922	CrCbGaD
Desloratadine—Amoxapine—DRD2—Parkinson's disease	0.000712	0.0783	CrCbGaD
Desloratadine—Amoxapine—HTR2A—Parkinson's disease	0.00055	0.0605	CrCbGaD
Desloratadine—Amoxapine—CYP2D6—Parkinson's disease	0.000503	0.0553	CrCbGaD
Desloratadine—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	7.62e-05	0.00121	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.56e-05	0.0012	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	7.44e-05	0.00118	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	7.43e-05	0.00118	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	7.41e-05	0.00118	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	7.33e-05	0.00116	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.32e-05	0.00116	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.32e-05	0.00116	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	7.19e-05	0.00114	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	7.19e-05	0.00114	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.16e-05	0.00114	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	7.1e-05	0.00113	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.07e-05	0.00112	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	7e-05	0.00111	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	7e-05	0.00111	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	6.95e-05	0.0011	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	6.64e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	6.63e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	6.63e-05	0.00105	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.61e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.6e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.59e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	6.54e-05	0.00104	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	6.51e-05	0.00103	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	6.51e-05	0.00103	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	6.5e-05	0.00103	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	6.37e-05	0.00101	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	6.37e-05	0.00101	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	6.36e-05	0.00101	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	6.07e-05	0.000963	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	5.99e-05	0.00095	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	5.91e-05	0.000938	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.86e-05	0.000931	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	5.83e-05	0.000925	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	5.75e-05	0.000913	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.53e-05	0.000878	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ND3—Parkinson's disease	5.52e-05	0.000877	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MCCC1—Parkinson's disease	5.52e-05	0.000877	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.44e-05	0.000864	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.39e-05	0.000856	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ND3—Parkinson's disease	5.39e-05	0.000856	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.39e-05	0.000856	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.35e-05	0.000849	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TALDO1—Parkinson's disease	5.19e-05	0.000824	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—OMD—Parkinson's disease	5.19e-05	0.000824	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	5.09e-05	0.000809	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.08e-05	0.000806	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ND3—Parkinson's disease	5.08e-05	0.000806	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—OMD—Parkinson's disease	5.07e-05	0.000804	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.07e-05	0.000804	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ND3—Parkinson's disease	5.04e-05	0.000799	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	5.04e-05	0.000799	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	5.03e-05	0.000799	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	5.02e-05	0.000798	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.01e-05	0.000795	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	4.92e-05	0.000781	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	4.83e-05	0.000766	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	4.8e-05	0.000763	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	4.8e-05	0.000762	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—OMD—Parkinson's disease	4.78e-05	0.000758	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.78e-05	0.000758	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—OMD—Parkinson's disease	4.73e-05	0.000751	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	4.73e-05	0.000751	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	4.73e-05	0.000751	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GCH1—Parkinson's disease	4.7e-05	0.000745	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	4.64e-05	0.000736	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GCH1—Parkinson's disease	4.58e-05	0.000727	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.57e-05	0.000725	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.53e-05	0.000719	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	4.49e-05	0.000713	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	4.49e-05	0.000712	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	4.36e-05	0.000692	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	4.33e-05	0.000687	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.32e-05	0.000686	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.3e-05	0.000683	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ND3—Parkinson's disease	4.3e-05	0.000683	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	4.29e-05	0.000682	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GCH1—Parkinson's disease	4.28e-05	0.00068	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.24e-05	0.000672	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	4.21e-05	0.000668	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.19e-05	0.000666	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—DBH—Parkinson's disease	4.19e-05	0.000664	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—FBP1—Parkinson's disease	4.19e-05	0.000664	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GBA—Parkinson's disease	4.19e-05	0.000664	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PENK—Parkinson's disease	4.11e-05	0.000652	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAG—Parkinson's disease	4.11e-05	0.000652	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GBA—Parkinson's disease	4.08e-05	0.000648	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—FBP1—Parkinson's disease	4.08e-05	0.000648	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—DBH—Parkinson's disease	4.08e-05	0.000648	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	4.08e-05	0.000647	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	4.06e-05	0.000645	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	4.06e-05	0.000645	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.05e-05	0.000642	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—OMD—Parkinson's disease	4.05e-05	0.000642	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.86e-05	0.000613	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GBA—Parkinson's disease	3.85e-05	0.000611	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.85e-05	0.000611	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—DBH—Parkinson's disease	3.85e-05	0.000611	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.84e-05	0.000609	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—DBH—Parkinson's disease	3.82e-05	0.000606	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—FBP1—Parkinson's disease	3.82e-05	0.000606	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GBA—Parkinson's disease	3.82e-05	0.000606	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	3.81e-05	0.000604	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	3.76e-05	0.000596	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	3.69e-05	0.000585	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	3.69e-05	0.000585	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.66e-05	0.000581	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.66e-05	0.000581	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.57e-05	0.000567	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	3.53e-05	0.00056	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	3.49e-05	0.000554	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.43e-05	0.000544	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.36e-05	0.000534	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.3e-05	0.000524	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GBA—Parkinson's disease	3.26e-05	0.000518	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—DBH—Parkinson's disease	3.26e-05	0.000518	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.26e-05	0.000518	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	3.25e-05	0.000516	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.1e-05	0.000492	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—DDC—Parkinson's disease	3.07e-05	0.000488	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	3.06e-05	0.000486	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—DDC—Parkinson's disease	3e-05	0.000476	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.98e-05	0.000473	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	2.97e-05	0.000471	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	2.95e-05	0.000469	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.9e-05	0.00046	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.86e-05	0.000455	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.84e-05	0.000452	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.83e-05	0.000449	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.83e-05	0.000448	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—DDC—Parkinson's disease	2.8e-05	0.000445	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—INSR—Parkinson's disease	2.74e-05	0.000435	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.67e-05	0.000424	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.66e-05	0.000422	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.65e-05	0.00042	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.000415	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.61e-05	0.000415	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGB—Parkinson's disease	2.59e-05	0.000411	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MAOB—Parkinson's disease	2.59e-05	0.00041	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	2.58e-05	0.00041	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	2.58e-05	0.000409	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.55e-05	0.000405	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	2.54e-05	0.000403	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MAOB—Parkinson's disease	2.52e-05	0.000401	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	2.49e-05	0.000395	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.46e-05	0.000391	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	2.41e-05	0.000382	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.4e-05	0.000381	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—DDC—Parkinson's disease	2.39e-05	0.00038	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.38e-05	0.000378	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.38e-05	0.000377	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.36e-05	0.000374	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.26e-05	0.000359	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	2.25e-05	0.000357	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.24e-05	0.000356	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.23e-05	0.000354	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	2.18e-05	0.000346	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	2.18e-05	0.000346	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.04e-05	0.000323	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.01e-05	0.00032	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.92e-05	0.000305	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.92e-05	0.000304	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.89e-05	0.000299	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.88e-05	0.000298	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CTGF—Parkinson's disease	1.84e-05	0.000292	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.83e-05	0.00029	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.77e-05	0.00028	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.76e-05	0.000279	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.75e-05	0.000278	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.74e-05	0.000277	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.74e-05	0.000276	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.73e-05	0.000275	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.72e-05	0.000273	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.72e-05	0.000272	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TH—Parkinson's disease	1.71e-05	0.000272	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.7e-05	0.000269	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TH—Parkinson's disease	1.67e-05	0.000265	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.64e-05	0.000261	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.62e-05	0.000257	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYCS—Parkinson's disease	1.61e-05	0.000255	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NGF—Parkinson's disease	1.6e-05	0.000254	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.6e-05	0.000254	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.6e-05	0.000254	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.58e-05	0.000252	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TH—Parkinson's disease	1.58e-05	0.00025	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TH—Parkinson's disease	1.56e-05	0.000248	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	1.53e-05	0.000242	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.51e-05	0.00024	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.5e-05	0.000238	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.5e-05	0.000238	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.47e-05	0.000233	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—COMT—Parkinson's disease	1.46e-05	0.000231	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.45e-05	0.00023	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.45e-05	0.00023	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.43e-05	0.000227	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—COMT—Parkinson's disease	1.42e-05	0.000226	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.42e-05	0.000225	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.41e-05	0.000225	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MAOA—Parkinson's disease	1.41e-05	0.000224	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.4e-05	0.000221	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.37e-05	0.000218	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.37e-05	0.000217	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.35e-05	0.000215	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.34e-05	0.000213	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TH—Parkinson's disease	1.33e-05	0.000212	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.33e-05	0.000212	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.33e-05	0.000211	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.33e-05	0.000211	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—COMT—Parkinson's disease	1.33e-05	0.000211	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.32e-05	0.00021	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.32e-05	0.000209	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.31e-05	0.000209	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.3e-05	0.000207	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.3e-05	0.000206	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.28e-05	0.000203	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.28e-05	0.000202	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.26e-05	0.0002	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.25e-05	0.000199	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GPX1—Parkinson's disease	1.24e-05	0.000198	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.23e-05	0.000194	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.21e-05	0.000193	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—INS—Parkinson's disease	1.21e-05	0.000192	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.18e-05	0.000187	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.17e-05	0.000186	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.16e-05	0.000185	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.15e-05	0.000182	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—COMT—Parkinson's disease	1.13e-05	0.00018	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.13e-05	0.000179	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.13e-05	0.000179	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.11e-05	0.000177	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—APOE—Parkinson's disease	1.1e-05	0.000174	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.08e-05	0.000172	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.07e-05	0.00017	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—APOE—Parkinson's disease	1.07e-05	0.00017	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.07e-05	0.00017	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.04e-05	0.000165	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.01e-05	0.00016	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—APOE—Parkinson's disease	9.99e-06	0.000159	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPX1—Parkinson's disease	9.94e-06	0.000158	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—INS—Parkinson's disease	9.36e-06	0.000149	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	9.17e-06	0.000146	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—INS—Parkinson's disease	9.14e-06	0.000145	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	9.02e-06	0.000143	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	8.96e-06	0.000142	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—INS—Parkinson's disease	8.61e-06	0.000137	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—APOE—Parkinson's disease	8.54e-06	0.000136	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—INS—Parkinson's disease	8.54e-06	0.000135	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	8.29e-06	0.000132	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—INS—Parkinson's disease	7.29e-06	0.000116	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—Parkinson's disease	5.3e-06	8.41e-05	CbGpPWpGaD
